Target Price | $74.00 |
Price | $75.06 |
Deviation |
1.41%
register free of charge
|
Number of Estimates | 11 |
11 Analysts have issued a price target Ryan Specialty Group 2026 .
The average Ryan Specialty Group target price is $74.00.
This is
1.41%
register free of charge
$92.00
22.57%
register free of charge
$56.00
25.39%
register free of charge
|
|
A rating was issued by 16 analysts: 7 Analysts recommend Ryan Specialty Group to buy, 7 to hold and 2 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Ryan Specialty Group stock has an average upside potential 2026 of
1.41%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion $ | 2.54 | 3.05 |
20.95% | 20.25% | |
EBITDA Margin | 30.65% | 33.15% |
5.53% | 8.14% | |
Net Margin | 3.50% | 5.08% |
12.89% | 44.94% |
11 Analysts have issued a sales forecast Ryan Specialty Group 2025 . The average Ryan Specialty Group sales estimate is
This results in the following potential growth metrics:
9 Analysts have issued an Ryan Specialty Group EBITDA forecast 2025. The average Ryan Specialty Group EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
6 Ryan Specialty Group Analysts have issued a net profit forecast 2025. The average Ryan Specialty Group net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | 0.71 | 1.24 |
36.54% | 74.65% | |
P/E | 59.60 | |
EV/Sales | 4.15 |
6 Analysts have issued a Ryan Specialty Group forecast for earnings per share. The average Ryan Specialty Group EPS is
This results in the following potential growth metrics and future valuations:
Ryan Specialty Group...
Analyst | Rating | Action | Date |
---|---|---|---|
UBS |
Locked
➜
Locked
|
Locked | Feb 26 2025 |
Citizens Capital Markets |
Locked
➜
Locked
|
Locked | Feb 21 2025 |
Keefe, Bruyette & Woods |
Locked
➜
Locked
|
Locked | Feb 21 2025 |
RBC Capital |
Locked
➜
Locked
|
Locked | Feb 21 2025 |
Wells Fargo |
Locked
➜
Locked
|
Locked | Feb 21 2025 |
Wells Fargo |
Locked
➜
Locked
|
Locked | Jan 14 2025 |
Keefe, Bruyette & Woods |
Locked
➜
Locked
|
Locked | Jan 10 2025 |
Analyst Rating | Date |
---|---|
Locked
UBS:
Locked
➜
Locked
|
Feb 26 2025 |
Locked
Citizens Capital Markets:
Locked
➜
Locked
|
Feb 21 2025 |
Locked
Keefe, Bruyette & Woods:
Locked
➜
Locked
|
Feb 21 2025 |
Locked
RBC Capital:
Locked
➜
Locked
|
Feb 21 2025 |
Locked
Wells Fargo:
Locked
➜
Locked
|
Feb 21 2025 |
Locked
Wells Fargo:
Locked
➜
Locked
|
Jan 14 2025 |
Locked
Keefe, Bruyette & Woods:
Locked
➜
Locked
|
Jan 10 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.